Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 136.00
+5.00 (3.82%)
Mar 10, 2026, 9:20 AM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 203.05 billion as of March 9, 2026. Its market cap has increased by 92.34% in one year.
Market Cap
203.05B
Enterprise Value
196.54B
Revenue
34.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
136.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 203.05B, an increase of 2,451.38%. That is a compound annual growth rate of 174.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 203.05B | -15.48% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 36.42B |
| Lin BioScience | 33.05B |
| Lumosa Therapeutics | 26.36B |
| Oneness Biotech | 26.27B |
| Polaris Group | 23.58B |
| Sunmax Biotechnology | 21.21B |
| EirGenix | 18.10B |
| TaiMed Biologics | 14.62B |